Rachel S. Signarvic, Ph.D. - Publications
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Organic Chemistry, Chemical Biology, De Novo Protein DesignYear | Citation | Score | |||
---|---|---|---|---|---|
2012 | Ma P, Cierniewska A, Signarvic R, Cieslak M, Kong H, Sinnamon AJ, Neubig RR, Newman DK, Stalker TJ, Brass LF. A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. Blood. 119: 1935-45. PMID 22210881 DOI: 10.1182/Blood-2011-10-387910 | 0.343 | |||
2010 | Signarvic RS, Cierniewska A, Stalker TJ, Fong KP, Chatterjee MS, Hess PR, Ma P, Diamond SL, Neubig RR, Brass LF. RGS/Gi2alpha interactions modulate platelet accumulation and thrombus formation at sites of vascular injury. Blood. 116: 6092-100. PMID 20852125 DOI: 10.1182/Blood-2010-05-283846 | 0.331 | |||
2010 | Ma P, Cierniewska A, Signarvic R, Sinnamon A, Cieslak M, Stalker TJ, Brass LF. Discovery of a New Signaling Complex Based on Spinophilin That Regulates Platelet Activation In Vitro and In Vivo Blood. 116: 161-161. DOI: 10.1182/Blood.V116.21.161.161 | 0.341 | |||
2009 | Signarvic RS, Degrado WF. Metal-binding dependent disruption of membranes by designed helices. Journal of the American Chemical Society. 131: 3377-84. PMID 19209932 DOI: 10.1021/Ja809580B | 0.473 | |||
2007 | Tang J, Signarvic RS, DeGrado WF, Gai F. Role of helix nucleation in the kinetics of binding of mastoparan X to phospholipid bilayers. Biochemistry. 46: 13856-63. PMID 17994771 DOI: 10.1021/Bi7018404 | 0.464 | |||
2003 | Signarvic RS, DeGrado WF. De novo design of a molecular switch: phosphorylation-dependent association of designed peptides. Journal of Molecular Biology. 334: 1-12. PMID 14596795 DOI: 10.1016/J.Jmb.2003.09.041 | 0.45 | |||
Show low-probability matches. |